Transfusions and early outcomes in anaemic patients undergoing off- or on-pump coronary artery bypass grafting

Andreas Koster1, Armin Zittermann2, Jan F Gummert2

  • 1Institute for Anesthesiology and Pain Therapy, Herz- und Diabeteszentrum NRW, Ruhr-University, Bochum, Germany.

Insights

Off-pump coronary artery bypass grafting (OPCAB) reduces transfusions and renal replacement therapy needs compared to on-pump coronary artery bypass grafting (ONCAB) in anemic patients. However, OPCAB increases wound infection risk, with similar mortality rates for both procedures.

Area of Science:

  • Cardiovascular Surgery
  • Anesthesiology
  • Critical Care Medicine

Background:

  • Preoperative anemia is common in patients undergoing coronary artery bypass grafting (CABG).
  • Both off-pump coronary artery bypass grafting (OPCAB) and on-pump coronary artery bypass grafting (ONCAB) are surgical options for CABG.
  • The choice between OPCAB and ONCAB may influence transfusion requirements and early outcomes, particularly in anemic patients.

Purpose of the Study:

  • To compare transfusion rates and early outcomes between OPCAB and ONCAB in patients with preoperative anemia.
  • To evaluate the impact of surgical approach on morbidity and mortality in this patient population.

Main Methods:

  • Retrospective comparison of 1621 consecutive patients with preoperative anemia undergoing OPCAB or ONCAB.
  • Propensity score analysis with inverse probability of treatment weighting was used.
  • Endpoints included transfusion rates, early morbidity (e.g., renal replacement therapy, wound infection, stroke), and mortality (30-day and 1-year).

Main Results:

  • OPCAB was associated with significantly fewer transfusions and a lower risk of postoperative renal replacement therapy compared to ONCAB.
  • Patients undergoing OPCAB had a higher risk of wound infections than those undergoing ONCAB.
  • There were no significant differences in perioperative stroke risk or 30-day and 1-year mortality between the OPCAB and ONCAB groups.

Conclusions:

  • Both OPCAB and ONCAB are feasible surgical approaches for patients with preoperative anemia, demonstrating similar early morbidity and mortality.
  • OPCAB offers benefits in reduced transfusion needs and lower risk of renal replacement therapy, but carries an increased risk of wound infections.
  • The choice of surgical technique should consider the trade-offs between transfusion avoidance, renal protection, and infection risk.

Related Concept Videos

Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
673
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
393